Joseph J Zeppa Selected Research

Superantigens

1/2018	Staphylococcal Superantigens Use LAMA2 as a Coreceptor To Activate T Cells.
9/2017	Nasopharyngeal infection by Streptococcus pyogenes requires superantigen-responsive Vβ-specific T cells.
1/2016	Nasopharyngeal Infection of Mice with Streptococcus pyogenes and In Vivo Detection of Superantigen Activity.
9/2014	Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo.
5/2014	Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph J Zeppa Research Topics

Disease

4	Infections 01/2020 - 05/2014
3	Septic Shock (Toxic Shock Syndrome) 01/2018 - 05/2014
2	Tuberculosis (Tuberculoses) 01/2023 - 01/2020
2	Scarlet Fever 09/2017 - 05/2014
1	Granuloma 01/2023
1	Pulmonary Tuberculosis 01/2020
1	Abscess 09/2014
1	Bacteremia 09/2014

Drug/Important Bio-Agent (IBA)

5	SuperantigensIBA 01/2018 - 05/2014
2	VaccinesIBA 01/2023 - 01/2020
2	Virulence Factors (Pathogenicity Factors)IBA 09/2017 - 05/2014
1	AntigensIBA 01/2023
1	BCG Vaccine FDA Link 01/2020
1	Calcium-Sensing ReceptorsIBA 01/2018
1	N- (2- hydroxy- 3- (2- cyano- 3- chlorophenoxy)propyl)- 1,1- dimethyl- 2- (2- nephthyl)ethylamineIBA 01/2018
1	staphylococcal enterotoxin BIBA 09/2017
1	Streptococcus pyogenes SpeA proteinIBA 09/2017
1	AntibodiesIBA 09/2017
1	Interleukin-12 (IL 12)IBA 09/2014
1	ChemokinesIBA 09/2014
1	Interferon-gamma (Interferon, gamma)IBA 09/2014
1	Staphylococcal enterotoxin AIBA 09/2014
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 09/2014
1	ToxoidsIBA 05/2014
1	Histocompatibility Antigens Class IIIBA 05/2014
1	ExotoxinsIBA 05/2014

Therapy/Procedure

1	Intravenous Administration 01/2020